TNFRSF9 and neoplasm: In the CD4+ compartment, both CD134 (1.590 vs. 0.811) and CD137 (0.570 vs. 0.273) were significantly upregulated in tumor tissues (both P < 0.05, Figures 4C, D), indicating enhanced activation potential or a regulatory phenotype skew.